Unknown

Dataset Information

0

Avelumab plus axitinib vs. sunitinib for advanced renal-cell carcinoma.

ABSTRACT:

SUBMITTER: Zhang Y 

PROVIDER: S-EPMC8798318 | biostudies-literature | 2019 Dec

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Avelumab plus axitinib <i>vs</i>. sunitinib for advanced renal-cell carcinoma.

Zhang Yue Y   Wu Shenhong S  

Translational cancer research 20191201 Suppl 6

Similar Datasets

Unknown Avelumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma.
| S-EPMC6716603 | biostudies-literature
Unknown A Cost-Effectiveness Analysis: First-Line Avelumab Plus Axitinib Versus Sunitinib for Advanced Renal-Cell Carcinoma.
| S-EPMC7225300 | biostudies-literature
Unknown Avelumab plus axitinib versus sunitinib in advanced renal cell carcinoma: biomarker analysis of the phase 3 JAVELIN Renal 101 trial.
| S-EPMC8493486 | biostudies-literature
Unknown Updated efficacy results from the JAVELIN Renal 101 trial: first-line avelumab plus axitinib versus sunitinib in patients with advanced renal cell carcinoma.
| S-EPMC8436592 | biostudies-literature
Unknown Association of Neutrophil-to-Lymphocyte Ratio with Efficacy of First-Line Avelumab plus Axitinib vs. Sunitinib in Patients with Advanced Renal Cell Carcinoma Enrolled in the Phase 3 JAVELIN Renal 101 Trial.
| S-EPMC9377757 | biostudies-literature
Unknown Efficacy of avelumab plus axitinib for advanced renal cell carcinoma as late-line therapy: A case report.
| S-EPMC9441301 | biostudies-literature
Unknown Extended follow-up from JAVELIN Renal 101: subgroup analysis of avelumab plus axitinib versus sunitinib by the International Metastatic Renal Cell Carcinoma Database Consortium risk group in patients with advanced renal cell carcinoma.
| S-EPMC10265611 | biostudies-literature
Unknown A Cost-Effectiveness Analysis of Nivolumab Plus Ipilimumab Versus Pembrolizumab Plus Axitinib and Versus Avelumab Plus Axitinib in First-Line Treatment of Advanced Renal Cell Carcinoma.
| S-EPMC9643032 | biostudies-literature
Unknown A Profile of Avelumab Plus Axitinib in the Treatment of Renal Cell Carcinoma.
| S-EPMC9275425 | biostudies-literature
Unknown Efficacy and correlative analyses of avelumab plus axitinib versus sunitinib in sarcomatoid renal cell carcinoma: post hoc analysis of a randomized clinical trial.
| S-EPMC8099757 | biostudies-literature